2001
DOI: 10.1007/s004320000209
|View full text |Cite
|
Sign up to set email alerts
|

Intestinal permeability in patients with chemotherapy-induced stomatitis

Abstract: Lactulose excretion after oral challenge, lactulose/mannitol, or lactulose/xylose ratio may be useful markers for intestinal involvement in chemotherapy-induced mucositis. Improvement of oral mucositis was associated with a significant decrease of intestinal permeability to lactulose. Testing of intestinal permeability by the present method may be useful to evaluate the effect of therapeutic interventions in patients with chemotherapy-induced mucositis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
39
0

Year Published

2004
2004
2017
2017

Publication Types

Select...
8
2

Relationship

3
7

Authors

Journals

citations
Cited by 57 publications
(42 citation statements)
references
References 12 publications
3
39
0
Order By: Relevance
“…The results of the current research are in agreement with previous researches which involved most chemical compounds used in remedy of cancer leading to decrease in weight and loss of appetite (aborexia), constipation [33] and Dysphagia and dyspesia and gastrointestinalis [34]. The DOX could cause disintegrates the epithelia of the elementary canal [35] and inflammation of mucosa (macositis) which both strongly refer to the toxic effects of DOX leading to the loss in weight [36].…”
Section: Discussionsupporting
confidence: 90%
“…The results of the current research are in agreement with previous researches which involved most chemical compounds used in remedy of cancer leading to decrease in weight and loss of appetite (aborexia), constipation [33] and Dysphagia and dyspesia and gastrointestinalis [34]. The DOX could cause disintegrates the epithelia of the elementary canal [35] and inflammation of mucosa (macositis) which both strongly refer to the toxic effects of DOX leading to the loss in weight [36].…”
Section: Discussionsupporting
confidence: 90%
“…Different laboratory methods have been proposed for monitoring of gastrointestinal toxicity of anticancer agents. Despite promising results, the measurement of intestinal permeability is difficult to be performed in practice (115,116). Citrulline represents another potential biomarker of intestinal toxicity of chemotherapy or radiation.…”
Section: Neopterin and Toxicity Of Anticancer Therapymentioning
confidence: 99%
“…In cancer patients, urinary neopterin is a prognostic biomarker, and it may also be used to monitor toxicity of anticancer therapy. For example, the gastrointestinal toxicity of anticancer therapy is difficult to monitor in the laboratory [45,46]. In a recent study, increased neopterin concentrations during radiotherapy for rectal cancer were associated with irradiated gut volume and predicted the occurrence of serious toxicity [47].…”
Section: Discussionmentioning
confidence: 99%